) The University of Pittsburgh's Mass Spectrometry Facility is committed to developing and expanding state-of-the-art techniques for mass spectral analysis of a wide variety of samples including peptides, proteins, lipids and carbohydrates. The Facility acts as a research support service for individuals within the University of Pittsburgh Cancer Institute (UPCI), and for other scientists at the University of Pittsburgh, as well as for outside investigators. This is the first request for inclusion of the Mass Spectrometry Facility as a CCSG core Facility, based on current utilization of the Facility to support the research of UPCI members, and the expanded usage of the Facility that is expected as more UPCI members become aware of the potential of the Facility for addressing specific molecular questions related to cancer research. The Facility currently offers triple quadrupole technology with electron ionization, fast atom bombardment and electrospray ionization sources on a Fisons Quattro II mass spectrometer. In addition to triple quadrupole technology, ion-trap and matrix assisted laser desorption ionization time-of -flight mass spectrometric technologies are available at Carnegie Mellon University. Both facilities synergize to offer a wide range of capabilities. The University of Pittsburgh Mass Spectrometry Facility is supervised by Dr. Andrew Amoscato, who is responsible for sample analyses, training and maintenance performed on the mass spectrometer. The Facility has provided extensive services (listed below) to several UPCI investigators over the last two years. It's long term goals are focused on extending the capabilities and applications of the instrument, which will include the acquisition of a dedicated HPLC and capillary electrophoresis instrumentation interfaced with the mass spectrometer directly on line, as well as upgrading the electrospray source to the more sensitive Z-Spray technology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA047904-12
Application #
6212131
Study Section
Subcommittee G - Education (NCI)
Project Start
1988-08-01
Project End
2004-07-30
Budget Start
Budget End
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Hartman, Douglas J; Ahmad, Fahad; Ferris, Robert L et al. (2018) Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma. Oral Oncol 86:278-287
Jin, Tao; Iordanova, Bistra; Hitchens, T Kevin et al. (2018) Chemical exchange-sensitive spin-lock (CESL) MRI of glucose and analogs in brain tumors. Magn Reson Med 80:488-495
Samal, Jasmine; Kelly, Samantha; Na-Shatal, Ali et al. (2018) Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model. JCI Insight 3:
Retseck, Janet; Nasr, Alexis; Lin, Yan et al. (2018) Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma. J Transl Med 16:184
Leibowitz, Brian J; Yang, Liheng; Wei, Liang et al. (2018) Targeting p53-dependent stem cell loss for intestinal chemoprotection. Sci Transl Med 10:
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Velásquez, Celestino; Amako, Yutaka; Harold, Alexis et al. (2018) Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1. Front Microbiol 9:713
Stabile, Laura P; Farooqui, Mariya; Kanterewicz, Beatriz et al. (2018) Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. J Thorac Oncol 13:399-412
Samanta, Suman K; Lee, Joomin; Hahm, Eun-Ryeong et al. (2018) Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells. Mol Carcinog 57:936-946
Zang, Yachen; Pascal, Laura E; Zhou, Yibin et al. (2018) ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells. Cancer Lett 415:198-207

Showing the most recent 10 out of 1187 publications